Peter I. Schrier

5.7k citations
90 papers · 4.9k · 1 hit paper · h-index 41

Impact in

  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Oncology top 2%
    • CAR-T cell therapy research

Papers in

    • Immunotherapy and Immune Responses 38
    • T-cell and B-cell Immunology 24
    • Immune Cell Function and Interaction 19
    • CAR-T cell therapy research 19
    • Cutaneous Melanoma Detection and Management 6

Peter I. Schrier

88 papers receiving 4.5k citations

Peter I. Schrier's Hit Papers

Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells 1983 · 524 citations
5240+14+28Years since publication100200300400500

Peers

Peter I. Schrier
Comparison fields: 5 of 109
  • Immunology 1.9k
  • Oncology 1.7k
  • Genetics 1.2k
  • Molecular Biology 2.4k
  • Ophthalmology 212
Replace David Berd with:
David Berd United States
Thomas D. Chittenden United States
Danielle Líénard Switzerland
Kiyoshi Ohtani Japan
Richard A. Ashmun United States
Kaito Toyoshima Japan
Thomas Wölfel Germany
Christopher Schmidt Australia
Giandomenico Russo Italy
Sibylle Mittnacht United Kingdom
Peter I. Schrier relative to David Berd United States David Berd's profile →
Citations per field
00.5×2×3×4.5×
David Berd · 1×
Citations per year

Countries citing papers authored by Peter I. Schrier

Since Specialization
Citations

This map shows the geographic impact of Peter I. Schrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter I. Schrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter I. Schrier more than expected).

Fields of papers citing papers by Peter I. Schrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter I. Schrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter I. Schrier. The network helps show where Peter I. Schrier may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter I. Schrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter I. Schrier Line = papers co-authored together Peter I. Schrier links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells
Hit paper breakdown →
1983524
2 1983320
3 1989237
4 1988225
5 1995194
6 1996155
7
Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
1996144
8 1985119
9 1993115
10 1982111
11 1995105
12 1989100
13 198388
14 199986
15 197383
16 197983
17 199678
18
cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines.
198874
19 199973
20 200672

About Peter I. Schrier

Peter I. Schrier is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Cancer Research, having authored 90 papers that have together received 4.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (38 papers), T-cell and B-cell Immunology (24 papers), CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (19 papers), Virus-based gene therapy research (18 papers), RNA Interference and Gene Delivery (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Immunology (1.9k citations), Oncology (1.7k citations), Genetics (1.2k citations), Molecular Biology (2.4k citations) and Ophthalmology (212 citations). Peter I. Schrier has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include A.J. van der Eb, Rene Bernards, Ada Houweling, Johannes L. Bos, R.T.M.J. Vaessen, Rogier Versteeg, D. J. Ruiter, Lucy T.C. Peltenburg, Susanne Osanto and Andrea van Elsas. Their work appears in journals such as International Journal of Cancer, Molecular and Cellular Biology, Virology, Immunogenetics and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact